1-35573946-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178548.4(TFAP2E):c.47G>A(p.Gly16Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000215 in 1,454,274 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178548.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFAP2E | NM_178548.4 | c.47G>A | p.Gly16Glu | missense_variant | 2/7 | ENST00000373235.4 | NP_848643.2 | |
TFAP2E-AS1 | NR_183386.1 | n.504+3413C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFAP2E | ENST00000373235.4 | c.47G>A | p.Gly16Glu | missense_variant | 2/7 | 1 | NM_178548.4 | ENSP00000362332 | P1 | |
TFAP2E-AS1 | ENST00000444348.3 | n.797+414C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00104 AC: 158AN: 151612Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000322 AC: 24AN: 74646Hom.: 0 AF XY: 0.000257 AC XY: 11AN XY: 42868
GnomAD4 exome AF: 0.000118 AC: 154AN: 1302554Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 69AN XY: 641538
GnomAD4 genome AF: 0.00104 AC: 158AN: 151720Hom.: 0 Cov.: 33 AF XY: 0.00138 AC XY: 102AN XY: 74094
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.47G>A (p.G16E) alteration is located in exon 2 (coding exon 2) of the TFAP2E gene. This alteration results from a G to A substitution at nucleotide position 47, causing the glycine (G) at amino acid position 16 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at